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Abstract. Unveiling pathological brain changes associated with Alzheimer’s
disease (AD) is a challenging task especially that people do not show
symptoms of dementia until it is late. Over the past years, neuroimaging
techniques paved the way for computer-based diagnosis and prognosis to
facilitate the automation of medical decision support and help clinicians
identify cognitively intact subjects that are at high-risk of developing
AD. As a progressive neurodegenerative disorder, researchers investi-
gated how AD affects the brain using different approaches: 1) image-based
methods where mainly neuroimaging modalities are used to provide early
AD biomarkers, and 2) network-based methods which focus on functional
and structural brain connectivities to give insights into how AD alters
brain wiring. In this study, we reviewed neuroimaging-based technical
methods developed for AD and mild-cognitive impairment (MCI) clas-
sification and prediction tasks, selected by screening all MICCAI pro-
ceedings published between 2010 and 2016. We included papers that
fit into image-based or network-based categories. The majority of pa-
pers focused on classifying MCI vs. AD brain states, which has enabled
the discovery of discriminative or altered brain regions and connections.
However, very few works aimed to predict MCI progression based on
early neuroimaging-based observations. Despite the high importance of
reliably identifying which early MCI patient will convert to AD, remain
stable or reverse to normal over months/years, predictive models are still
lagging behind.
1 Introduction
Alzheimer’s disease (AD), which is the most common form of dementia, is still
today an incurable degenerative disease. It affects 5-8% of all people above 60
years of age, increasing to around 40% of people older than 90% [1]. AD is also
known as an irreversible, progressive disorder that destroys neurons which leads
to deficits in cognitive functions such as memory and thinking skills. Clinical
diagnosis can be supported by biomarkers that detect the presence or absence
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of the disease. However, identifying such biomarkers, especially in a very early
stage, remains challenging as brain changes due to AD occur even before amnes-
tic symptoms appear [2]. The number of people diagnosed with dementia in the
UK is expected to rise to over 2 million by 2051 with an estimated cost at be-
tween 17 billion and 18 billion a year (Dementia UK report1). Hence, identifying
Alzheimer’s disease (AD) earlier before the neurodegeneration is too severe and
where treatment is not currently available, might aid in preventing AD onset.
Specifically, patients initially diagnosed with mild cognitive impairment (MCI)
are known to be a clinically heterogeneous group with different patterns of brain
atrophy [3], of which some cases will not progress to AD [4]. To examine the
borders between MCI and AD, Magnetic Resonance Imaging (MRI) was exten-
sively used as a non-invasive imaging modality to track changes in brain images
of MCI patients as they remain stable, progress to AD, or reverse to normal.
Brain dementia MRI data are rapidly growing with emerging international re-
search initiatives aiming to massively collect large high-quality brain images with
structural, diffusion and functional imaging modalities, e.g., the public ADNI
(Alzheimer’s Disease Neuroimaging Initiative) dataset [5]. However, despite the
large body of publications on AD and major advances in neuroimaging technolo-
gies, brain image analysis and machine-learning methods, dementia research has
not progressed as desired. Fundamentally, there are two major reasons for this.
First, the majority of methods developed for investigating AD stages have
focused on learning how to classify AD vs. MCI or normal control (NC) sub-
jects [6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24]. A conventional classi-
fication method would help identify features discriminating between MCI and
AD groups; however, it would not allow to identify MCI patients with longer-
term followup who will convert to AD after the first MR acquisition timepoint
(i.e., baseline). Recently, a challenge on computer-aided diagnosis (CAD) of de-
mentia based on structural MRI, namely CAD-Dementia [4], was launched to
evaluate the performance of 29 algorithms from 15 research teams in classifying
NC/MCI/AD using a public dataset. However, such dementia challenges have
not focused on finding very early biomarkers of prodromal AD, characteristic of
the presymptomatic MCI phase of the disease preceding severe cognitive decline,
which is a major issue for current international research on AD.
Second, although advanced machine-learning and medical imaging analysis
methods for dementia CAD have demonstrated high performance in the liter-
ature [4], they are not publicly shared for comparability, reproducibility, and
generalizability to unseen data [25]. Although the data for the CAD-dementia
challenge is available, the developed methods were not made available for re-
searchers to test on other datasets. A notable exception based on multivariate
analysis [26] overlooks the richness and efficiency of recently published machine-
learning and data analysis methods for brain disease diagnosis and prognosis
[27]. In the following sections, we provide in-depth analysis of AD-related classi-
1 https://www.alzheimers.org.uk/about-us/policy-and-influencing/
dementia-uk-report
fication and evolution prediction methods from various neuroimaging modalities
and identify the gaps in the state-of-the-art.
2 Selection criteria
The analyzed papers in this review were identified from MICCAI conference from
2010 until 2016. We conducted our search using different combinations of the fol-
lowing key words: functional, structural, fMRI, DTI, magnetic resonance imag-
ing, network, brain, connectivity, diffusion, Alzheimer’s disease, mild cognitive
impairment, classification, prediction, diagnosis, AD, MCI, biomarker, demen-
tia. We identified 28 papers based on the given search criteria. It is noteworthy
that works developed for segmentation tasks and those not focusing primarily
on AD/MCI classification or prediction were excluded from this review. The
included papers are displayed in Fig. 1. We grouped them into two categories:
‘image-based methods’ and ‘network-based methods’.
3 Image-based methods
Fig. 1: Identified AD/MCI classifica-
tion papers published in MICCAI 2010–
2016 proceedings.
We identified 17 papers that use MR
images for dementia state classifica-
tion. These mainly used hippocampal
atrophy and gray matter volume for
classifying NC, MCI, and AD brain
states. This can be explained by the
fact that AD is related to gray mat-
ter loss [28] and the shape of subcor-
tical structures (particularly the hip-
pocampus) [29]. To predict clinical de-
cline at the MCI stage and progres-
sion to AD, [24] created p-maps from
the differences in the shape of the hip-
pocampus between NC and AD subjects and showed increased rates by identi-
fying local regions of interest (ROIs) within the hippocampus using statistical
shape models. In a different work, [30] used (left and right) caudate nucleus, and
putamen as additional features to hippocampal features to present a system for
AD classification using a self-smoothing operator. Other papers suggested the
combination of grading measure with HC volume. Specifically, [6] proposed a
new method to robustly detect the hippocampal atrophy patterns based on a
nonlocal means estimation framework. Combined with HC volume, the grading
measure (i.e, the atrophy degree in AD context) led to a success classification
rate of 90% between NC and AD subjects.
[7] used two different modalities (MRI + PET) where each subject is repre-
sented by two 93-dimensional feature vectors that represent gray matter volume
and the average intensity of PET images of 93 ROIs. A novel multi-task learn-
ing based feature selection method was proposed to preserve the complementary
information conveyed by the two modalities and reached 94% accuracy in dis-
tinguishing between AD and NC subjects. In the same context, [9] proposed
a manifold regularized multi-task learning framework to jointly select features
from multi-modality (MRI + FDG-PET) data as well as [10] and [31,12,13].
Similarly, [8] used the same features in addition to three CSF biomarkers and
introduced a deep learning method that discovers the non-linear correlations
among features which improves the AD, MCI and MCI-C diagnosis accuracy.
In [32], a novel Multifold Bayesian Kernelization (MBK) method was proposed
to analyze multi-modal MRI biomarkers including average cerebral metabolic
rate from PET data, gray matter volume, solidity and convexity features for AD
and MCI classification. Another study [11] introduced a different approach to
improve AD/NC and p-MCI/s-MCI classification. Basically, it learns a maxi-
mum margin representation using multiple atlases jointly with the classification
model which resulted in 90% accuracy for AD/NC classification and 73% for
p-MCI/s-MCI.
Fig. 2: Distributions of the identified
image-based and network dementia diag-
nosis and prognosis methods published in
MICCAI 2010-2016 proceedings.
We also identified two landmark
papers [33,34], which devised machine
learning frameworks for predicting de-
mentia evolution at later timepoints.
[34] proposed a novel canonical fea-
ture selection method to fuse infor-
mation from different imaging modal-
ities (MRI+PET). Specifically, orig-
inal features (gray matter volume
and average intensity of PET images)
are projected into a common space.
Hence, they become more comparable
and easier to depict their relationship
in order to predict clinical scores of
Alzheimer’s disease. Using the same
features, [33] applied a low rank sub-
space clustering to cluster the data,
then used a low rank matrix comple-
tion framework to identify pMCI pa-
tients and their time of conversion.
4 Network based methods
In this section, we identified 12 papers where the majority (6 papers) used func-
tional networks (derived from fMRI) for dementia diagnosis and prognosis. The
remaining studies mainly used structural brain networks (derived from MRI) or
fused both networks to enhance AD classification accuracy.
4.1 Functional network
It has been reported that the neurodegenerative process of AD reflects disturbed
functional connectivity between brain regions [35,36]. These alterations are usu-
ally measured using resting-state functional MRI (rs-fMRI). Multiple methods
have been used for AD diagnosis. For instance, [18] proposed a constrained
sparse linear regression model associated with the least absolute shrinkage and
selection operator (LASSO) that generates topologically consistent functional
connectivity networks from rs-fMRI, thereby improving NC/MCI classification
compared with traditional correlation-based methods [36,37]. [19] introduced a
sparse multivariate autoregressive (MAR) modeling to infer effective connectiv-
ity from rs-fMRI data and demonstrated its superiority compared to correlation
based functional connectivity approaches.
[23] proposed a novel weighted sparse group representation method for brain
network modeling, which integrates link strength, group structure as well as
sparsity in a unified framework. This models the interactions among multiple
brain regions unlike pairwise Pearson correlation and showed superior results in
the task of MCI and NC classification. Since simply relying on pairwise func-
tional connectivity between brain regions overlooks how their relationship might
be affected at a higher-order level by AD, many studies introduced a functional
connectivity hyper-network (FCHN) to infer additional information for AD clas-
sifcation. [20] constructed a FCHN using sparse representation modeling where
three sets of brain regions are exracted to be fed into a multi-kernel SVM clas-
sifier and evaluated on a real MCI dataset. [38] also used a high-order func-
tional connectivity network (HOFC) for MCI classification but generated multi-
ple HOFC networks using hierarchical clustering to further ensemble them with
a selective feature fusion method. This approach produced better classification
performance than simple use of a single HOFC network.
Dynamic FC. While many studies assumed stationarity on the functional
networks over time [39,40], recent studies in neuroscience have shown that func-
tional organization changes spontaneously over time [41]. For instance, [21] in-
troduced a novel method to model functional dynamics in rs-fMRI for MCI
identification. Specifically, a deep network was designed to unravel the non-
linear relationships among ROIs in a hierarchical manner and achieved a high
classification performance.
4.2 Structural network
Recent findings showed that AD induces a disrupted topology in the structural
network characterized by an early damage to synapses and a degeneration of
axons [42]. These alterations are basically investigated using MRI with different
proposed techniques. In [14], a graph matching framework was devised to match
(i) a source graph, where each node encodes a vector that describes regional gray
matter volume or cortical thickness features, and (ii) a target graph that includes
class label and clinical scores. This approach estimates a target vector for each
sample without neglecting its relation with other samples. [15] proposed a view-
aligned hypergraph learning (VAHL) method using multi-modality data (MRI,
PET, and CSF) for AD/MCI diagnosis where each view corresponds to a specific
modality or a combination of several ones. This method can explicitly model the
coherence among the views which led to a boost of 4.6% in classification accuracy.
[43] proposed a two-stage (query prediction + ranking) medical image retrieval
technique with application to MCI diagnosis assistance. This framework was
evaluated using three imaging modalities: T1-weighted imaging (T1-w), Diffusion
Tensor Imaging (DTI) and Arterial Spin Labeling (ASL).
5 Functional and structural networks
Relying on either structural or functional brain networks may overlook the com-
plementary information that can be leveraged to improve diagnosis and prog-
nosis. For this purpose, [17] integrated two imaging modalities (DTI and fMRI)
using a multi-kernel support vector machine (SVM) to improve classification
performance where DTI images are parcellated into 90 regions. Then, different
structural networks are generated, each conveying a different biophysical prop-
erty of the brain (e.g., fibers count, fractional anisotropy and mean diffusivity).
Additionally, functional connectivity matrices were constructed based on Pear-
son correlation coefficient to encode the connectivity strength between a pair of
ROIs. Furthermore, [44] proposed a centralized hypergraph learning method to
model the relationship among subjects using multiple MRIs. Specifically, four
MRI sequences were used including T1-weighted MRI (T1), Diffusion Tensor
Imaging (DTI), Resting-State functional MRI (RS-fMRI) and Arterial Spin La-
beling (ASL) perfusion imaging. This allows to extract supplementary informa-
tion captured by different neuroimaging data, thereby enhancing the quality of
MCI diagnosis.
6 Results and discussion
In this paper, we identified and reviewed 28 works on AD diagnosis and prog-
nosis published in MICCAI proceedings from 2010-2016. Table. 1 displays the
different identified papers, while revealing five major gaps that need to be ad-
dressed to move dementia research field forward. First, all identified MICCAI
papers focused on AD/MCI/NC classification, except for two papers [33,34],
which proposed machine-learning frameworks to predict MCI conversion to AD.
Undeniably, accurate discrimination between AD and MCI subjects is an im-
portant task to solve as it helps devise more individualized and patient-tailored
treatment strategies [45]. However, an accurate prognosis for MCI patients is
far more important for providing the optimal treatment and management of
the disorder in very early stage. Indeed, early biomarkers identification might
help reduce MCI to AD conversion rate. Therefore, predictive models need to
be developed to fill this gap and propel the field of MCI prognosis forward.
Such lack of studies could be due to the scarcity of spatiotemporal neuroimag-
ing data where each patient is scanned multiple times. One way to tackle this
is by adopting good practices in data analysis and sharing which can promote
reliability and collaboration [25]. Second, the classification performance of the
proposed technical methods for dementia largely varied with multiple peaks and
drops from 2010-2016. This can give insights into the heterogeneity and variabil-
ity of the disease within subjects and how challenging it is to find an accurate
method that works for all cases. In fact, no single approach can be sufficient as
each has complementary merits and limitations. Third, comparing these methods
is very difficult since they used different approaches and datasets, it is somewhat
hard to tell which one performs better if they are not compared against the same
baseline methods and evaluated on the same dataset. Fourth, all network-based
analysis methods overlooked how dementia states affect the relationship between
cortical regions in morphology in both stability, conversion, or reversal MCI evo-
lution scenarios. To fill this gap and noting that several studies [27,46] reported
that morphological features of the brain, such as cortical thickness, can be af-
fected in neurological disorders, one can use the recently proposed morphological
brain networks for dementia diagnosis [47,48,49,50]. Last, none of these works
proposed a technique for predicting the full trajectory of brain shape changes
as MCI progresses towards AD, remains stable, or reverses to normal. Besides,
the absence of network-based predictive models is remarkable (Table 1). As
such, the use of advanced network and shape analysis methods, using machine
learning, could prove fruitful for both classification [47,48,49,50] and prediction
tasks.
7 Conclusion
In this review paper, we examined neuroimaging-based methods for dementia
diagnosis and prognosis published in MICCAI 2010-2016 proceedings. The ma-
jority of reviewed studies focused on NC, MCI and AD classification tasks using
image-based methods or network-based methods including structural and func-
tional brain networks. We noted that very few works developed frameworks to
predict MCI conversion to AD at later observations. While the ultimate goal
of classification is to provide a computer-aided diagnosis for better clinical de-
cisions, predicting future progression of early demented brains from a baseline
observation (i.e., a single timepoint) remains a priority as it might help delay
conversion from MCI to AD when early treatment is addressed to the patient.
Undoubtedly, predictive intelligence for early dementia diagnosis is still lagging
behind, holding various untapped potentials for translational medicine.
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